Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) shares rose 1.9% during mid-day trading on Monday . The company traded as high as $28.41 and last traded at $28.34. Approximately 91,472 shares were traded during trading, a decline of 21% from the average daily volume of 115,649 shares. The stock had previously closed at $27.81.
Innovator IBD 50 ETF Price Performance
The firm’s 50-day moving average price is $29.60 and its 200-day moving average price is $28.96. The stock has a market cap of $68.02 million, a P/E ratio of 33.68 and a beta of 1.24.
Hedge Funds Weigh In On Innovator IBD 50 ETF
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in FFTY. Raymond James Financial Inc. purchased a new position in shares of Innovator IBD 50 ETF in the 4th quarter worth approximately $284,000. Tower Research Capital LLC TRC increased its stake in shares of Innovator IBD 50 ETF by 47.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 15,225 shares of the company’s stock valued at $435,000 after buying an additional 4,883 shares during the period. Comprehensive Financial Planning Inc. PA purchased a new stake in shares of Innovator IBD 50 ETF in the 4th quarter worth approximately $437,000. Two Sigma Investments LP bought a new stake in Innovator IBD 50 ETF during the 4th quarter valued at $1,138,000. Finally, Jane Street Group LLC lifted its position in shares of Innovator IBD 50 ETF by 51.5% during the third quarter. Jane Street Group LLC now owns 49,781 shares of the company’s stock valued at $1,339,000 after buying an additional 16,912 shares during the last quarter.
Innovator IBD 50 ETF Company Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Featured Stories
- Five stocks we like better than Innovator IBD 50 ETF
- How to Capture the Benefits of Dividend Increases
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- 3 Small Caps With Big Return Potential
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- What is a Death Cross in Stocks?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
